FOGARI E.

The aim of this study was to evaluate the effects of ω-3 PUFA (n-3 PUFA) on lipid profile and insulin resistance biomarkers. Patients were assigned to receive placebo or n-3 PUFA 1g three times a day, during the meals, for 6 months. We evaluated: body mass index (BMI), body weight, fasting plasma glucose (FPG), fasting plasma insulin (FPI),...